BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17709281)

  • 21. Harnessing immune responses against Plasmodium for rational vaccine design.
    Douradinha B; Doolan DL
    Trends Parasitol; 2011 Jun; 27(6):274-83. PubMed ID: 21531627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.
    Vanderberg JP
    Vaccine; 2009 Jan; 27(1):2-9. PubMed ID: 18973784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine.
    Ripley Ballou W
    Microbes Infect; 2007 May; 9(6):761-6. PubMed ID: 17412630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mosquito production mooted as fast track to malaria vaccine.
    Butler D
    Nature; 2003 Oct; 425(6957):437. PubMed ID: 14523404
    [No Abstract]   [Full Text] [Related]  

  • 25. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designer Parasites: Genetically Engineered
    Goswami D; Minkah NK; Kappe SHI
    J Immunol; 2019 Jan; 202(1):20-28. PubMed ID: 30587570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
    Hafalla JC; Rai U; Bernal-Rubio D; Rodriguez A; Zavala F
    J Infect Dis; 2007 Dec; 196(12):1827-35. PubMed ID: 18190264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune evasion by malaria parasites: a challenge for vaccine development.
    Casares S; Richie TL
    Curr Opin Immunol; 2009 Jun; 21(3):321-30. PubMed ID: 19493666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parasitology. Malaria vaccines: back to the future?
    Waters AP; Mota MM; van Dijk MR; Janse CJ
    Science; 2005 Jan; 307(5709):528-30. PubMed ID: 15681372
    [No Abstract]   [Full Text] [Related]  

  • 30. [Perspectives and challenges of malaria vaccine. Why we must do more].
    Leroy O
    Bull Acad Natl Med; 2007 Oct; 191(7):1249-59; discussion 1259-60. PubMed ID: 18447047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.
    Moorthy VS; Diggs C; Ferro S; Good MF; Herrera S; Hill AV; Imoukhuede EB; Kumar S; Loucq C; Marsh K; Ockenhouse CF; Richie TL; Sauerwein RW
    Vaccine; 2009 Sep; 27(42):5719-25. PubMed ID: 19654061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case for whole-parasite malaria vaccines.
    Wykes M; Good MF
    Int J Parasitol; 2007 Jun; 37(7):705-12. PubMed ID: 17408673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-erythrocytic malaria vaccines: towards greater efficacy.
    Hill AV
    Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting memory: a prospective readout for malaria vaccines?
    Minigo G; Scalzo K; Flanagan KL; Plebanski M
    Trends Parasitol; 2007 Aug; 23(8):341-3. PubMed ID: 17586093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malaria vaccines: if at first you don't succeed..
    Tongren JE; Zavala F; Roos DS; Riley EM
    Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    DobaƱo C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria vaccine development: persistent challenges.
    Vaughan AM; Kappe SH
    Curr Opin Immunol; 2012 Jun; 24(3):324-31. PubMed ID: 22521906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between malaria parasites and the host immune system.
    Engwerda CR; Good MF
    Curr Opin Immunol; 2005 Aug; 17(4):381-7. PubMed ID: 15950450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections.
    Doolan DL; Hoffman SL
    Philos Trans R Soc Lond B Biol Sci; 1997 Sep; 352(1359):1361-7. PubMed ID: 9355128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.